Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Hodge

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Geriatric Psychiatry|November 11, 2015
Patients' and carers' experiences of UK memory servicesEmma Hailey, Sophie Hodge, Alistair Burns, et al.
The Journal of ECT|December 9, 2016
A Further Decrease in the Rates of Administration of Electroconvulsive Therapy in EnglandNicky Buley, Emma Copland, Sophie Hodge, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Journal of the American Heart Association|October 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PADShea Hogan, Michael Szarek, E Sebastian Debus, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Geriatric Psychiatry|November 11, 2015
Patients' and carers' experiences of UK memory servicesEmma Hailey, Sophie Hodge, Alistair Burns, et al.
The Journal of ECT|December 9, 2016
A Further Decrease in the Rates of Administration of Electroconvulsive Therapy in EnglandNicky Buley, Emma Copland, Sophie Hodge, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Journal of the American Heart Association|October 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PADShea Hogan, Michael Szarek, E Sebastian Debus, et al.
Pageof 1